Merck & Co.
13.12.2010 • News
Elmar Schnee to Leave Merck KGaA
02.12.2010 • News
Merck Set to Buy Biotech Firm SmartCells
22.10.2010 • News
Sanofi, Merck Begin Vet Drugs Sell-Off
02.08.2010 • News
White Knight Could Be Elusive For Genzyme
20.07.2010 • News
J&J Plant in Merck Venture Cited by U.S. FDA
28.06.2010 • News
Big Pharma Stocks Could Rally in the Next Year
27.05.2010 • News
Roche Maintains Focus as Industry Faces Cutbacks
26.05.2010 • News
Teva Tests Biosimilar Version of Roche's Rituxan
17.05.2010 • News
Teva CEO Sees Gains From U.S. Health Reform Law
12.05.2010 • News
Merck to Seek 5 New Drug Approvals This Year
05.05.2010 • News
Merck Profit Beats, but 2010 Forecast Cautious
29.04.2010 • News
Merck Promotes Frazier as Clark Nears Retirement
26.04.2010 • News
Merck Health-reform Costs Below Rivals
22.04.2010 • News
Codexis Prices at Bottom of Range
19.04.2010 • News
Oracle Buying Drug Software Maker Phase Forward
29.03.2010 • News
Bayer Still Out To Buy, Not Sell, Vet Businesses
16.03.2010 • News
GTx and U.S. Merck End Collaboration Agreement
22.01.2010 • News
Merck & Co. Acquires Avecia Biologics
Lilly Deutschland GmbH
EvaluatePharma
Iktos AI
Sanofi S.A.
Codexis
Merck & Co
DCAT - Drug, Chemical & Associated Technologies Association
Daiichi Sankyo Europe GmbH
Oracle Germany
PureTech Systems
Thomson Reuters
F. Hoffmann-La Roche Ltd
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
Datamonitor Group
ARC Advisory Group GmbH & Co KG
Bayer AG
SchüllerConsulting
GlobalData